{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:50Z","timestamp":1786119650673,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/med.0b013e3283400945","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T01:44:46Z","timestamp":1294969486000},"page":"535-539","source":"Crossref","is-referenced-by-count":16,"title":["Renal bone disease"],"prefix":"10.1097","volume":"17","author":[{"given":"Stuart M","family":"Sprague","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20211004","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"R2-8-20211004","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Renal osteodystrophy","volume":"333","author":"Hruska","year":"1995","journal-title":"N Engl J Med"},{"key":"R4-8-20211004","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure: an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"R6-8-20211004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.ackd.2006.10.010","article-title":"Bone health in chronic kidney disease-mineral and bone disease","volume":"14","author":"Gal-Moscovici","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"issue":"Suppl 3","key":"R7-8-20211004","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.2215\/CJN.01100307","article-title":"Role of bone biopsy in stages 3 to 4 chronic kidney disease","volume":"3","author":"Gal-Moscovici","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R8-8-20211004","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/snep.2002.35965","article-title":"Renal osteodystrophy in chronic renal failure","volume":"22","author":"Ho","year":"2002","journal-title":"Semin Nephrol"},{"key":"R9-8-20211004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"R10-8-20211004","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1-5: achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R11-8-20211004","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5414\/CNP63284","article-title":"New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels","volume":"63","author":"Gal-Moscovici","year":"2005","journal-title":"Clin Nephrol"},{"key":"R12-8-20211004","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","article-title":"Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients","volume":"41","author":"Bervoets","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R13-8-20211004","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ndt\/gfg116","article-title":"Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis","volume":"18","author":"Spasovski","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R14-8-20211004","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1523-1755.2005.00603.x","article-title":"25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy","volume":"68","author":"Coen","year":"2005","journal-title":"Kidney Int"},{"key":"R15-8-20211004","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"R16-8-20211004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bone.2006.09.011","article-title":"Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways","volume":"40","author":"Alikhani","year":"2007","journal-title":"Bone"},{"key":"R17-8-20211004","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00000441-199906000-00009","article-title":"Relative hypoparathyroidism and adynamic bone disease","volume":"317","author":"Mucsi","year":"1999","journal-title":"Am J Med Sci"},{"key":"R18-8-20211004","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"R19-8-20211004","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/jcp.34.11.1285","article-title":"Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis","volume":"34","author":"Parkinson","year":"1981","journal-title":"J Clin Pathol"},{"key":"R20-8-20211004","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1185\/03007998109114275","article-title":"The role of vitamin D metabolites in the osteomalacia of renal disease","volume":"7","author":"Kanis","year":"1981","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 3","key":"R21-8-20211004","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2215\/CJN.02500607","article-title":"Effects of treatment of renal osteodystrophy on bone histology","volume":"3","author":"Malluche","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R22-8-20211004","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"R23-8-20211004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"R24-8-20211004","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1185\/030079907X242719","article-title":"A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate","volume":"23","author":"Sprague","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"R25-8-20211004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ajkd.2009.01.269","article-title":"Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources","volume":"54","author":"Sherman","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R26-8-20211004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5414\/CNP72252","article-title":"Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study","volume":"72","author":"Sprague","year":"2009","journal-title":"Clin Nephrol"},{"key":"R27-8-20211004","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ki.2010.113","article-title":"Use of vitamin D in chronic kidney disease patients","volume":"78","author":"Gal-Moscovici","year":"2010","journal-title":"Kidney Int"},{"key":"R28-8-20211004","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2215\/CJN.03850609","article-title":"Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease","volume":"5","author":"Sprague","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-8-20211004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP.14.1.18","article-title":"Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"14","author":"Andress","year":"2008","journal-title":"Endocr Pract"},{"key":"R30-8-20211004","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2215\/CJN.06141108","article-title":"Simultaneous control of PTH and CaxP is sustained over three years of treatment with cinacalcet HCl","volume":"4","author":"Sprague","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01266029-201012000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:49:58Z","timestamp":1786042198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01266029-201012000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e3283400945","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}